Plain language summary of five-year overall survival update from the HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma (liver cancer)

Rimassa, Lorenza

;Chan, Stephen L.;Sangro, Bruno;Lau, George;Kudo, Masatoshi;Reig, Maria;Breder, Valeriy;Ryu, Min-Hee;Ostapenko, Yurii;Sukeepaisarnjaroen, Wattana;Varela, Maria;Tougeron, David;Crysler, Oxana V.;Bouattour, Mohamed;Dao, Tu Van;Tam, Vincent C.;Faccio, Adilson;Furuse, Junji;Jeng, Long-Bin;Kang, Yoon Koo;Kelley, Robin K.;Kurland, John F.;Balaji, Kavitha;Abou-Alfa, Ghassan K.

2026-01-01